skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Structural characterization of the ICOS/ICOS-L immune complex reveals high molecular mimicry by therapeutic antibodies

Journal Article · · Nature Communications
 [1];  [2];  [3];  [2]; ORCiD logo [3]
  1. The Hospital for Sick Children Research Inst., Toronto, ON (Canada); Univ. of the Basque Country (UPV/EHU), Bilbao (Spain)
  2. The Hospital for Sick Children Research Inst., Toronto, ON (Canada)
  3. The Hospital for Sick Children Research Inst., Toronto, ON (Canada); Univ. of Toronto, ON (Canada)

The inducible co-stimulator (ICOS) is a member of the CD28/B7 superfamily, and delivers a positive co-stimulatory signal to activated T cells upon binding to its ligand (ICOS-L). Dysregulation of this pathway has been implicated in autoimmune diseases and cancer, and is currently under clinical investigation as an immune checkpoint blockade. Here, we describe the molecular interactions of the ICOS/ICOS-L immune complex at 3.3 Å resolution. A central FDPPPF motif and residues within the CC’ loop of ICOS are responsible for the specificity of the interaction with ICOS-L, with a distinct receptor binding orientation in comparison to other family members. Furthermore, our structure and binding data reveal that the ICOS N110 N-linked glycan participates in ICOS-L binding. In addition, we report crystal structures of ICOS and ICOS-L in complex with monoclonal antibodies under clinical evaluation in immunotherapy. Strikingly, antibody paratopes closely mimic receptor-ligand binding core interactions, in addition to contacting peripheral residues to confer high binding affinities. Our results uncover key molecular interactions of an immune complex central to human adaptive immunity and have direct implications for the ongoing development of therapeutic interventions targeting immune checkpoint receptors.

Research Organization:
Argonne National Lab. (ANL), Argonne, IL (United States). Advanced Photon Source (APS); Brookhaven National Lab. (BNL), Upton, NY (United States). National Synchrotron Light Source II (NSLS-II)
Sponsoring Organization:
European Union (EU); Canadian Institutes of Health Research (CIHR); Canadian Institute for Advanced Research (CIFAR); Canada Research Chairs Program; National Cancer Institute (NCI); National Institute of General Medical Sciences (NIGMS); National Institutes of Health (NIH); USDOE Office of Science (SC), Biological and Environmental Research (BER)
Grant/Contract Number:
790012; PJT-148811; S10 OD012289; AC02-06CH11357; SC0012704; P41GM111244
OSTI ID:
1682336
Journal Information:
Nature Communications, Vol. 11, Issue 1; ISSN 2041-1723
Publisher:
Nature Publishing GroupCopyright Statement
Country of Publication:
United States
Language:
ENGLISH

References (64)

The Interaction Properties of Costimulatory Molecules Revisited journal August 2002
Cemiplimab: First Global Approval journal November 2018
De novo design of potent and selective mimics of IL-2 and IL-15 journal January 2019
Synthesis and Crystal Structure of the Copper Complex of 7,16-Bis(2-hydroxy-5-methylbenzyl)-1,4,10,13-tetraoxa-7,16-diazacyclooctadecane journal January 2004
Crystal structure of the B7-1/CTLA-4 complex that inhibits human immune responses journal March 2001
Structural basis for co-stimulation by the human CTLA-4/B7-2 complex journal March 2001
T Follicular Helper Cell Differentiation, Function, and Roles in Disease journal October 2014
Crystal Structure of a Shark Single-Domain Antibody V Region in Complex with Lysozyme journal September 2004
Collaboration gets the most out of software journal September 2013
ICOS is essential for effective T-helper-cell responses journal January 2001
Molecular mechanism of PD-1/PD-L1 blockade via anti-PD-L1 antibodies atezolizumab and durvalumab journal July 2017
A variant of yellow fluorescent protein with fast and efficient maturation for cell-biological applications journal January 2002
Association of Pembrolizumab With Tumor Response and Survival Among Patients With Advanced Melanoma journal April 2016
Cutting Edge: Identification of GL50, a Novel B7-Like Protein That Functionally Binds to ICOS Receptor journal February 2000
B7h, a Novel Costimulatory Homolog of B7.1 and B7.2, Is Induced by TNFα journal October 1999
Covalent Dimerization of CD28/CTLA-4 and Oligomerization of CD80/CD86 Regulate T Cell Costimulatory Interactions journal October 1996
A TRAF-like motif of the inducible costimulator ICOS controls development of germinal center TFH cells via the kinase TBK1 journal May 2016
Muscle fibres and cultured muscle cells express the B7.1/2-related inducible co-stimulatory molecule, ICOSL: implications for the pathogenesis of inflammatory myopathies journal May 2003
Simultaneous blockade of co-stimulatory signals, CD28 and ICOS, induced a stable tolerance in rat heart transplantation journal October 2003
The ICOS-ligand B7-H2, expressed on human type II alveolar epithelial cells, plays a role in the pulmonary host defense system journal April 2006
Homozygous loss of ICOS is associated with adult-onset common variable immunodeficiency journal February 2003
Structure and T Cell Inhibition Properties of B7 Family Member, B7-H3 journal May 2013
Improved Survival with Ipilimumab in Patients with Metastatic Melanoma journal August 2010
XDS journal January 2010
Inference of Macromolecular Assemblies from Crystalline State journal September 2007
Brief Report: A Randomized, Double-Blind, Parallel-Group, Placebo-Controlled, Multiple-Dose Study to Evaluate AMG 557 in Patients With Systemic Lupus Erythematosus and Active Lupus Arthritis journal May 2018
ICOS:ICOS-Ligand Interaction Is Required for Type 2 Innate Lymphoid Cell Function, Homeostasis, and Induction of Airway Hyperreactivity journal March 2015
ICOS is an inducible T-cell co-stimulator structurally and functionally related to CD28 journal January 1999
ICOS controls the pool size of effector-memory and regulatory T cells journal February 2008
A framework for organizing cancer-related variations from existing databases, publications and NGS data using a High-performance Integrated Virtual Environment (HIVE) journal January 2014
Characterization of Human Inducible Costimulator Ligand Expression and Function journal May 2000
Further study of anti-ICOS immunotherapy for rat cardiac allograft rejection journal August 2008
Structural Basis for Broad and Potent Neutralization of HIV-1 by Antibody VRC01 journal July 2010
Mouse Inducible Costimulatory Molecule (ICOS) Expression Is Enhanced by CD28 Costimulation and Regulates Differentiation of CD4 + T Cells journal November 2000
Nonimmune cell–derived ICOS ligand functions as a renoprotective αvβ3 integrin–selective antagonist journal March 2019
A recurring motif for antibody recognition of the receptor-binding site of influenza hemagglutinin journal February 2013
Follicular T-helper cell recruitment governed by bystander B cells and ICOS-driven motility journal April 2013
Inducible T‐cell co‐stimulator: Signaling mechanisms in T follicular helper cells and beyond journal August 2019
Features and development of Coot journal March 2010
Ligand Binding Sites of Inducible Costimulator and High Avidity Mutants with Improved Function journal April 2002
Inhibition of Chronic Rejection and Development of Tolerogenic T Cells after ICOS-ICOSL and CD40-CD40L Co-stimulation Blockade journal January 2005
T-cell co-stimulation through B7RP-1 and ICOS journal December 1999
Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma journal July 2015
PHENIX: a comprehensive Python-based system for macromolecular structure solution journal January 2010
Regulation of CD4 T cell activation and effector function by inducible costimulator (ICOS) journal June 2010
Solution structure of human CTLA-4 and delineation of a CD80/CD86 binding site conserved in CD28 journal July 1997
Structural Basis of Inducible Costimulator Ligand Costimulatory Function: Determination of the Cell Surface Oligomeric State and Functional Mapping of the Receptor Binding Site of the Protein journal September 2006
Engagement of the ICOS pathway markedly enhances efficacy of CTLA-4 blockade in cancer immunotherapy journal March 2014
Review Article. cell Surface Carbohydrates as Prognostic Markers in Human Carcinomas journal August 1996
Inducible T-cell co-stimulator ligand (ICOSL) blockade leads to selective inhibition of anti-KLH IgG responses in subjects with systemic lupus erythematosus journal April 2016
Intratumoral modulation of the inducible co-stimulator ICOS by recombinant oncolytic virus promotes systemic anti-tumour immunity journal February 2017
Characterization of a new human B7-related protein: B7RP-1 is the ligand to the co-stimulatory protein ICOS journal October 2000
ICOS is critical for CD40-mediated antibody class switching journal January 2001
A two-step, two-signal model for the primary activation of precursor helper T cells journal January 1999
Crystal structure of a soluble CD28-Fab complex journal February 2005
Inducible costimulator (ICOS) potentiates TCR-induced calcium flux by augmenting PLCγ1 activation and actin remodeling journal November 2016
The PD-1/PD-L1 complex resembles the antigen-binding Fv domains of antibodies and T cell receptors journal February 2008
Eradication of Triple-Negative Breast Cancer Cells by Targeting Glycosylated PD-L1 journal February 2018
Antigen presentation by chemically modified splenocytes induces antigen-specific T cell unresponsiveness in vitro and in vivo. journal February 1987
CCR5 Mimicry by Sulfated Human Anti-HIV-1 Antibodies journal July 2003
ICOS co-stimulatory receptor is essential for T-cell activation and function journal January 2001
Inducible costimulator promotes helper T-cell differentiation through phosphoinositide 3-kinase journal November 2009
Phaser crystallographic software journal July 2007
Structural Basis of Enhanced Crystallizability Induced by a Molecular Chaperone for Antibody Antigen-Binding Fragments journal February 2018

Similar Records

Structure of the Human Activating Natural Cytotoxicity Receptor NKp30 Bound to its Tumor Cell Ligand B7-H6
Journal Article · Sat Dec 31 00:00:00 EST 2011 · Journal of Experimental Medicine · OSTI ID:1682336

Crystal Structure of the Complex Between Programmed Death-1 (PD-1) and its Ligand PD-L2
Journal Article · Tue Jan 01 00:00:00 EST 2008 · Proceedings of the National Academy of Sciences of the USA · OSTI ID:1682336

Interferon-β signal may up-regulate PD-L1 expression through IRF9-dependent and independent pathways in lung cancer cells
Journal Article · Sat Dec 15 00:00:00 EST 2018 · Biochemical and Biophysical Research Communications · OSTI ID:1682336